Bisphosphonate Therapy in Primary Hyperparathyroidism (multiple letters)

Journal of Bone and Mineral Research

Volumn 18, Issue 10, 2003, Pages 1889-

  Hershman, Jerome M ^a   Hassani, Sima ^b   Braunstein, Glenn D ^c   Geola, Flor ^d   Brickman, Arnold ^h   Seibel, Markus J ^e   Bilezikian, John P ^f   Potts Jr , John T ^g  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b KAISER PERMANENTE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f New York Presbyterian Columbia University Medical Center   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM CHANNEL STIMULATING AGENT; CINACALCET; PARATHYROID HORMONE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; FEMUR NECK; HUMAN; LETTER; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0142241111     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2003.18.10.1889     Document Type: Letter

References (0)